BRIEF-Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code

Reuters2022-09-03

Sept 2 (Reuters) - Allena Pharmaceuticals Inc :

* ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION FOR RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE UNITED STATES CODE

* ALLENA PHARMACEUTICALS INC - HAS APPOINTED MATTHEW FOSTER AS THE COMPANY’S CHIEF RESTRUCTURING OFFICER, EFFECTIVE AS OF SEPTEMBER 2, 2022

* ALLENA PHARMACEUTICALS- TERMINATED EMPLOYMENT OF SUBSTANTIALLY ALL OF ITS EMPLOYEES, INCLUDING LOUIS BRENNER, PRESIDENT AND CEO AND RICHARD KATZ, CFO

* ALLENA PHARMACEUTICALS- INTENDS TO CONTINUE TO OPERATE ITS BUSINESS AT REDUCED LEVEL AS A “DEBTOR-IN-POSSESSION” UNDER THE JURISDICTION OF COURT

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2264573808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-03 05:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2264573808","market":"us","top_or_hot":-1,"title":"BRIEF-Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code","media":"Reuters","content":"<html><body><p>Sept 2 (Reuters) - Allena Pharmaceuticals Inc   :</p><p>   * ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION FOR RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE UNITED STATES CODE</p><p>   * ALLENA PHARMACEUTICALS INC - HAS APPOINTED MATTHEW FOSTER AS THE COMPANY’S CHIEF RESTRUCTURING OFFICER, EFFECTIVE AS OF SEPTEMBER 2, 2022</p><p>   * ALLENA PHARMACEUTICALS-  TERMINATED EMPLOYMENT OF SUBSTANTIALLY ALL OF ITS EMPLOYEES, INCLUDING LOUIS BRENNER, PRESIDENT AND CEO AND RICHARD KATZ, CFO</p><p>   * ALLENA PHARMACEUTICALS-  INTENDS TO CONTINUE TO OPERATE ITS BUSINESS AT REDUCED LEVEL AS A “DEBTOR-IN-POSSESSION” UNDER THE JURISDICTION OF COURT</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-03 05:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sept 2 (Reuters) - Allena Pharmaceuticals Inc   :   * ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION FOR RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE UNITED STATES CODE   * ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABP","symbol_name":"Landos Biopharma, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2264573808","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2264573808","pubTimestamp":1662154153,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 2 (Reuters) - Allena Pharmaceuticals Inc   :   * ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABP":"Landos Biopharma, Inc.","BK4139":"生物科技","BK4007":"制药","APR":"Apria, Inc.","BK4023":"应用软件","ONTF":"ON24, Inc.","CGEM":"Cullinan Therapeutics","BK4196":"保健护理服务","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc.","BK4082":"医疗保健设备"},"translate_title":"Allena Pharmaceuticals Inc.根据《美国法典》第11章第11章的规定自愿申请救济","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"ONTF":1,"SANA":1,"ALNA":0.9},"content_text":"Sept 2 (Reuters) - Allena Pharmaceuticals Inc   :   * ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION FOR RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE UNITED STATES CODE   * ALLENA PHARMACEUTICALS INC - HAS APPOINTED MATTHEW FOSTER AS THE COMPANY’S CHIEF RESTRUCTURING OFFICER, EFFECTIVE AS OF SEPTEMBER 2, 2022   * ALLENA PHARMACEUTICALS-  TERMINATED EMPLOYMENT OF SUBSTANTIALLY ALL OF ITS EMPLOYEES, INCLUDING LOUIS BRENNER, PRESIDENT AND CEO AND RICHARD KATZ, CFO   * ALLENA PHARMACEUTICALS-  INTENDS TO CONTINUE TO OPERATE ITS BUSINESS AT REDUCED LEVEL AS A “DEBTOR-IN-POSSESSION” UNDER THE JURISDICTION OF COURTFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2264573808"}